Solara Active Pharma Rights Shares Conversion

Date: August 19, 2026

Board Meeting Outcomes

The Rights Issue Committee of the Board of Directors approved via Circular Resolution on August 19, 2026 the conversion of 2,79,582 partly paid-up Rights Equity Shares into fully paid-up equity shares of face value of ₹10 per share bearing ISIN INE624Z01016.

Conversion Details

The conversion comprises two categories of shares:

• 2,23,051 Rights Equity Shares of face value of ₹10 each, having ₹262.50 paid per share (comprising ₹7 towards face value and ₹255.50 towards premium) bearing ISIN-IN9624Z01022. These shares had their Second and Final Call monies of ₹112.50 per share (comprising ₹3 towards face value and ₹109.5 towards premium) received.

• 56,531 Rights Equity Shares of face value of ₹10 each, having ₹131.25 paid per share (comprising ₹3.50 towards face value and ₹127.75 towards premium) bearing ISIN-IN9624Z01014. These shares had their First Call Money and Second and Final Call monies of ₹243.75 per share (comprising ₹6.5 towards face value and ₹237.25 towards premium) received.

Current Capital Structure

As of August 19, 2026, the paid-up capital of the Company is ₹48,16,16,569 divided into:

• 4,80,81,817 fully paid-up equity shares having a face value of ₹10 each bearing ISIN INE624Z01016
• 59,419 equity shares of ₹7 partly paid-up bearing ISIN IN9624Z01022
• 1,09,276 equity shares of ₹3.50 partly paid-up bearing ISIN IN9624Z01014

Next Steps

The Company shall take necessary steps for giving effect to the requisite corporate actions and obtaining listing and trading approvals in respect of the Converted Rights Equity Shares.